Related Experiment Video
Updated: Mar 28, 2026

A Guide to Generating and Using hiPSC Derived NPCs for the Study of Neurological Diseases
Published on: February 21, 2015
Modeling psychiatric disorders with patient-derived iPSCs
Zhexing Wen1, Kimberly M Christian1, Hongjun Song2
1Institute for Cell Engineering, Johns Hopkins University School of Medicine, Baltimore, MD 21205, USA; Department of Neurology, Johns Hopkins University School of Medicine, Baltimore, MD 21205, USA.
Abstract:
Psychiatric disorders are heterogeneous disorders characterized by complex genetics, variable symptomatology, and anatomically distributed pathology, all of which present challenges for effective treatment. Current treatments are often blunt tools used to ameliorate the most severe symptoms, often at the risk of disrupting functional neural systems, thus there is a pressing need to develop rational therapeutics. Induced pluripotent stem cells (iPSCs) reprogrammed from patient somatic cells offer an unprecedented opportunity to recapitulate both normal and pathologic human tissue and organ development, and provides new approaches for understanding disease mechanisms and for drug discovery with higher predictability of their effects in humans. Here we review recent progress and challenges in using human iPSCs for modeling neuropsychiatric disorders and developing novel therapeutic strategies.
Insights
Induced pluripotent stem cells (iPSCs) offer a new way to study complex psychiatric disorders. This research reviews how iPSCs can model disease and aid in developing more predictable, targeted therapeutics.
Area of Science:
- Neuroscience
- Stem Cell Biology
- Genetics
Background:
- Psychiatric disorders are complex with challenging genetics and variable symptoms.
- Current treatments lack specificity and can disrupt neural systems.
- There is a need for rational therapeutics with higher predictability.
Purpose of the Study:
- To review the use of induced pluripotent stem cells (iPSCs) for modeling neuropsychiatric disorders.
- To discuss the potential of iPSCs in developing novel therapeutic strategies.
Main Methods:
- Review of recent progress in utilizing human iPSCs.
- Analysis of challenges in iPSC-based disease modeling and drug discovery.
Main Results:
- iPSCs can recapitulate normal and pathological human tissue development.
- iPSCs provide a platform for understanding disease mechanisms.
- iPSCs facilitate drug discovery with higher predictability in humans.
Conclusions:
- Human iPSCs represent a powerful tool for studying neuropsychiatric disorders.
- iPSC technology offers promising avenues for developing targeted and effective therapeutics.
More Related Videos
08:52Modeling Osteosarcoma Using Li-Fraumeni Syndrome Patient-derived Induced Pluripotent Stem Cells
Published on: June 13, 2018
10:43Developing HiPSC Derived Serum Free Embryoid Bodies for the Interrogation of 3-D Stem Cell Cultures Using Physiologically Relevant Assays
Published on: July 20, 2017
Related Concept Videos
EPS and iPS Cells in Disease Research
Induced Pluripotent Stem Cells
Somatic...
Induced Pluripotent Stem Cells
Induced Pluripotent Stem Cells
iPS Cell Differentiation